Authors: Al Safarjalani, ON Zhou, XJ Naguib, FNM Goudgaon, NM Schinazi, RF el Kouni, MH

Citation: On. Al Safarjalani et al., Modulation of the pharmacokinetics of endogenous plasma uridine by 5-(phenylthio) acyclouridine, a uridine phosphorylase inhibitor: implications for chemotherapy, CANC CHEMOT, 48(2), 2001, pp. 145-150

Authors: Ashour, OM Naguib, FNM Goudgaon, NM Schinazi, RF el Kouni, MH

Citation: Om. Ashour et al., Effect of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on plasma concentration of uridine released from 2 ',3 ',5 '-tri-O-acetyluridine, a prodrug of uridine: relevance to uridine rescue in chemotherapy, CANC CHEMOT, 46(3), 2000, pp. 235-240

Authors: Ashour, OM Al Safarjalani, ON Naguib, FNM Goudgaon, NM Schinazi, RF el Kouni, MH

Citation: Om. Ashour et al., Modulation of plasma uridine concentration by 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase: relevance to chemotherapy, CANC CHEMOT, 45(5), 2000, pp. 351-361

Authors: el Kouni, MH Goudgaon, NM Rafeeq, M Al Safarjalani, ON Schinazi, RF Naguib, FNM

Citation: Mh. El Kouni et al., 5-phenylthioacyclouridine: A potent and specific inhibitor of uridine phosphorylase, BIOCH PHARM, 60(6), 2000, pp. 851-856

Authors: Ashour, OM Naguib, FNM Goudgaon, NM Schinazi, RF el Kouni, MH

Citation: Om. Ashour et al., Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitorof uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2 '-deoxyuridine against murine colon tumor C26-10, BIOCH PHARM, 60(5), 2000, pp. 687-692